hypoxanthine and Neuroblastoma

hypoxanthine has been researched along with Neuroblastoma in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's2 (33.33)18.2507
2000's3 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aglianò, AM; Barbato, S; Frati, L; Gazzaniga, P; Giacomello, A; Guaglianone, MR; Messina, E; Micheli, V; Morrone, S1
Barile, L; Giacomello, A; Lupi, F; Messina, E1
Chiba, P; Gharehbaghi, K; Lhotka, C; Pillwein, K; Ressmann, G; Schuchter, K; Szalay, SM; Szekeres, T1
Alfinito, P; Ledeen, RW; Lu, ZH; Wu, G1
Connolly, GP; Ma, MH; Stacey, NC1
Barankiewicz, J; Cohen, A; Kaplinsky, C; Yeger, H1

Other Studies

6 other study(ies) available for hypoxanthine and Neuroblastoma

ArticleYear
Guanine nucleotide depletion triggers cell cycle arrest and apoptosis in human neuroblastoma cell lines.
    International journal of cancer, 2004, Mar-01, Volume: 108, Issue:6

    Topics: Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Nucleus; Dose-Response Relationship, Drug; Down-Regulation; Flow Cytometry; G1 Phase; Gene Expression Regulation, Neoplastic; Guanine Nucleotides; Guanosine Diphosphate; Guanosine Triphosphate; Humans; Hypoxanthine; Immunohistochemistry; Immunosuppressive Agents; Inhibitor of Apoptosis Proteins; Microfilament Proteins; Microtubule-Associated Proteins; Muscle Proteins; Mycophenolic Acid; Neoplasm Proteins; Neuroblastoma; Prodrugs; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins p21(ras); Reverse Transcriptase Polymerase Chain Reaction; Survivin; Time Factors; Tumor Suppressor Protein p53

2004
Potential role of mycophenolate mofetil in the management of neuroblastoma patients.
    Nucleosides, nucleotides & nucleic acids, 2004, Volume: 23, Issue:8-9

    Topics: Allopurinol; Antineoplastic Agents; Apoptosis; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Guanine; Humans; Hypoxanthine; Hypoxanthine Phosphoribosyltransferase; Immunosuppressive Agents; Mycophenolic Acid; Neuroblastoma; Niflumic Acid; Phenotype

2004
Synergistic action of tiazofurin with hypoxanthine and allopurinol in human neuroectodermal tumor cell lines.
    Biochemical pharmacology, 1993, Dec-03, Volume: 46, Issue:11

    Topics: Allopurinol; Cell Division; Dose-Response Relationship, Drug; Drug Synergism; Guanosine Monophosphate; Humans; Hypoxanthine; Hypoxanthines; IMP Dehydrogenase; Neuroblastoma; Ribavirin; Tumor Cells, Cultured

1993
Opioid receptor and calcium channel regulation of adenylyl cyclase, modulated by GM1, in NG108-15 cells: competitive interactions.
    Neurochemical research, 1997, Volume: 22, Issue:10

    Topics: Adenylate Cyclase Toxin; Adenylyl Cyclases; Aminopterin; Binding, Competitive; Calcium Channels; Cholera Toxin; Cyclic AMP; Enkephalin, Leucine-2-Alanine; Fluorescent Dyes; G(M1) Ganglioside; Glioma; Hybrid Cells; Hypoxanthine; Neuroblastoma; Pertussis Toxin; Receptors, Opioid; Thymidine; Tumor Cells, Cultured; Virulence Factors, Bordetella

1997
Hypoxanthine impairs morphogenesis and enhances proliferation of a neuroblastoma model of Lesch Nyhan syndrome.
    Journal of neuroscience research, 2001, Mar-15, Volume: 63, Issue:6

    Topics: Animals; Cell Division; Culture Media; Energy Metabolism; Hypoxanthine; Lesch-Nyhan Syndrome; Neuroblastoma; Neurons; Rats; Tumor Cells, Cultured

2001
Purine metabolism in human neuroblastoma cell lines.
    Advances in experimental medicine and biology, 1986, Volume: 195 Pt B

    Topics: Adenine; Adenosine; Cell Line; Guanosine; Humans; Hypoxanthine; Hypoxanthines; Neuroblastoma; Nucleosides; Purine Nucleosides; Purine Nucleotides; Purines; Tubercidin

1986
chemdatabank.com